These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38786051)

  • 1. Effects of the Dual FAAH/MAGL Inhibitor AKU-005 on Trigeminal Hyperalgesia in Male Rats.
    Greco R; Demartini C; Francavilla M; Zanaboni AM; Facchetti S; Palmisani M; Franco V; Tassorelli C
    Cells; 2024 May; 13(10):. PubMed ID: 38786051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine.
    Greco R; Demartini C; Zanaboni A; Casini I; De Icco R; Reggiani A; Misto A; Piomelli D; Tassorelli C
    Neurobiol Dis; 2021 Jan; 147():105157. PubMed ID: 33129939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent dual MAGL/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain.
    Della Pietra A; Krivoshein G; Ivanov K; Giniatullina R; Jyrkkänen HK; Leinonen V; Lehtonen M; van den Maagdenberg AMJM; Savinainen J; Giniatullin R
    J Headache Pain; 2023 Apr; 24(1):38. PubMed ID: 37038131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of FAAH-Inhibitor JZP327A in an Experimental Rat Model of Migraine.
    Greco R; Francavilla M; Demartini C; Zanaboni AM; Facchetti S; Palmisani M; Franco V; Tassorelli C
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine.
    Greco R; Demartini C; Zanaboni AM; Francavilla M; Reggiani A; Realini N; Scarpelli R; Piomelli D; Tassorelli C
    J Headache Pain; 2022 Jul; 23(1):79. PubMed ID: 35799128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine.
    Greco R; Francavilla M; Demartini C; Zanaboni AM; Sodergren MH; Facchetti S; Pacchetti B; Palmisani M; Franco V; Tassorelli C
    J Headache Pain; 2023 May; 24(1):48. PubMed ID: 37138206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine.
    Greco R; Demartini C; Francavilla M; Zanaboni AM; Tassorelli C
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine.
    Della Pietra A; Giniatullin R; Savinainen JR
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
    Nozaki C; Markert A; Zimmer A
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1388-96. PubMed ID: 25910421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing.
    Greco R; Demartini C; Zanaboni AM; Tassorelli C
    J Headache Pain; 2018 Jul; 19(1):51. PubMed ID: 30003352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of CGRP Receptor: Central and Peripheral Mechanisms and Mediators in an Animal Model of Chronic Migraine.
    Greco R; Demartini C; Francavilla M; Zanaboni AM; Tassorelli C
    Cells; 2022 Sep; 11(19):. PubMed ID: 36231054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAAH inhibition as a preventive treatment for migraine: A pre-clinical study.
    Greco R; Demartini C; Zanaboni AM; Tumelero E; Reggiani A; Misto A; Piomelli D; Tassorelli C
    Neurobiol Dis; 2020 Feb; 134():104624. PubMed ID: 31629892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the transient receptor potential ankyrin type-1 (TRPA1) channel in migraine pain: evaluation in an animal model.
    Demartini C; Tassorelli C; Zanaboni AM; Tonsi G; Francesconi O; Nativi C; Greco R
    J Headache Pain; 2017 Sep; 18(1):94. PubMed ID: 28884307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-1 inhibits nitroglycerin-induced trigeminal activation of oxidative stress, calcitonin gene-related peptide and c-Fos expression.
    Won L; Kraig RP
    Neurosci Lett; 2021 Apr; 751():135809. PubMed ID: 33713748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin gene-related peptide facilitates sensitization of the vestibular nucleus in a rat model of chronic migraine.
    Zhang Y; Zhang Y; Tian K; Wang Y; Fan X; Pan Q; Qin G; Zhang D; Chen L; Zhou J
    J Headache Pain; 2020 Jun; 21(1):72. PubMed ID: 32522232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: Targets and anti-migraine mechanisms.
    Greco R; Demartini C; Zanaboni AM; Redavide E; Pampalone S; Toldi J; Fülöp F; Blandini F; Nappi G; Sandrini G; Vécsei L; Tassorelli C
    Cephalalgia; 2017 Nov; 37(13):1272-1284. PubMed ID: 27919017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of peripheral FAAH blockade on NTG-induced hyperalgesia--evaluation of URB937 in an animal model of migraine.
    Greco R; Bandiera T; Mangione AS; Demartini C; Siani F; Nappi G; Sandrini G; Guijarro A; Armirotti A; Piomelli D; Tassorelli C
    Cephalalgia; 2015 Oct; 35(12):1065-76. PubMed ID: 25608877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the endocannabinoid system in an animal model of migraine: evaluation in cerebral areas of rat.
    Greco R; Gasperi V; Sandrini G; Bagetta G; Nappi G; Maccarrone M; Tassorelli C
    Cephalalgia; 2010 Mar; 30(3):296-302. PubMed ID: 19515121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglia P2X4R-BDNF signalling contributes to central sensitization in a recurrent nitroglycerin-induced chronic migraine model.
    Long T; He W; Pan Q; Zhang S; Zhang D; Qin G; Chen L; Zhou J
    J Headache Pain; 2020 Jan; 21(1):4. PubMed ID: 31937253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.